The Association Between the Extent of Glioblastoma Resection and Survival in Light of MGMT Promoter Methylation in 326 Patients With Newly Diagnosed IDH-Wildtype Glioblastoma
Background: The association between contrast enhanced (CE) and non-contrast enhanced (NCE) tumor resection and survival in patients with glioblastoma in relation to molecular subtypes is poorly understood. The aim of this study was to assess the association between CE and NCE tumor resection and sur...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.01087/full |
id |
doaj-bc7d65cb5dab46aa8884ea83479cffbc |
---|---|
record_format |
Article |
spelling |
doaj-bc7d65cb5dab46aa8884ea83479cffbc2020-11-25T03:45:20ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2020-07-011010.3389/fonc.2020.01087550278The Association Between the Extent of Glioblastoma Resection and Survival in Light of MGMT Promoter Methylation in 326 Patients With Newly Diagnosed IDH-Wildtype GlioblastomaFatih Incekara0Fatih Incekara1Marion Smits2Sebastian R. van der Voort3Hendrik Jan Dubbink4Peggy N. Atmodimedjo5Johan M. Kros6Arnaud J. P. E. Vincent7Martin van den Bent8Department of Neurosurgery, Brain Tumor Center, Erasmus MC—University Medical Center Rotterdam, Rotterdam, NetherlandsDepartment of Radiology and Nuclear Medicine, Erasmus MC—University Medical Center Rotterdam, Rotterdam, NetherlandsDepartment of Radiology and Nuclear Medicine, Erasmus MC—University Medical Center Rotterdam, Rotterdam, NetherlandsDepartment of Radiology and Nuclear Medicine, Erasmus MC—University Medical Center Rotterdam, Rotterdam, NetherlandsDepartment of Pathology, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, NetherlandsDepartment of Pathology, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, NetherlandsDepartment of Pathology, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, NetherlandsDepartment of Neurosurgery, Brain Tumor Center, Erasmus MC—University Medical Center Rotterdam, Rotterdam, NetherlandsDepartment of Neurology, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, NetherlandsBackground: The association between contrast enhanced (CE) and non-contrast enhanced (NCE) tumor resection and survival in patients with glioblastoma in relation to molecular subtypes is poorly understood. The aim of this study was to assess the association between CE and NCE tumor resection and survival in light of MGMT promoter methylation in newly diagnosed IDH-wildtype glioblastoma.Materials and methods: Patients with newly diagnosed IDH-wildtype glioblastoma who underwent surgery were eligible. CE and NCE tumor volumes were assessed on pre- and post-operative MRI scans and extent of resection was calculated. The association between CE and NCE tumor resection and survival was evaluated using multivariable Cox proportional hazards models and Kaplan Meier estimates.Results: Three hundred and twenty-six patients were included: 177 (54.3%) with and 149 (45.7%) without MGMT methylation. Multivariable Cox proportional hazards models stratified for MGMT methylation identified age ≤ 65y (HR 0.63; 95% CI, 0.49–0.81; p < 0.0001), chemoradiation (HR 0.13; 95% CI, 0.09–0.19; p < 0.0001), maximal CE tumor resection (HR 0.58; 95% CI, 0.39–0.87; p = 0.009), ≥ 30% NCE tumor resection (HR 0.71; 95% CI, 0.53–0.93; p = 0.014), and minimal residual CE tumor volume (HR 0.64; 95% CI, 0.46–0.88 p = 0.007) as being associated with longer overall survival. Kaplan Meier estimates showed that extensive surgery was more beneficial for patients with MGMT methylated glioblastoma.Conclusions: This study shows an association between maximal CE tumor resection, ≥30% NCE tumor resection, minimal residual CE tumor volume, and longer overall survival in patients with newly diagnosed IDH wildtype glioblastoma. Intraoperative imaging and stimulation mapping may be used to pursue safe and maximal resection. In future research, the safety aspect of maximizing tumor resection needs to be addressed.https://www.frontiersin.org/article/10.3389/fonc.2020.01087/fullglioblastomaextent of resectioncontrast enhancednon-contrast enhancedsurvivalMGMT |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Fatih Incekara Fatih Incekara Marion Smits Sebastian R. van der Voort Hendrik Jan Dubbink Peggy N. Atmodimedjo Johan M. Kros Arnaud J. P. E. Vincent Martin van den Bent |
spellingShingle |
Fatih Incekara Fatih Incekara Marion Smits Sebastian R. van der Voort Hendrik Jan Dubbink Peggy N. Atmodimedjo Johan M. Kros Arnaud J. P. E. Vincent Martin van den Bent The Association Between the Extent of Glioblastoma Resection and Survival in Light of MGMT Promoter Methylation in 326 Patients With Newly Diagnosed IDH-Wildtype Glioblastoma Frontiers in Oncology glioblastoma extent of resection contrast enhanced non-contrast enhanced survival MGMT |
author_facet |
Fatih Incekara Fatih Incekara Marion Smits Sebastian R. van der Voort Hendrik Jan Dubbink Peggy N. Atmodimedjo Johan M. Kros Arnaud J. P. E. Vincent Martin van den Bent |
author_sort |
Fatih Incekara |
title |
The Association Between the Extent of Glioblastoma Resection and Survival in Light of MGMT Promoter Methylation in 326 Patients With Newly Diagnosed IDH-Wildtype Glioblastoma |
title_short |
The Association Between the Extent of Glioblastoma Resection and Survival in Light of MGMT Promoter Methylation in 326 Patients With Newly Diagnosed IDH-Wildtype Glioblastoma |
title_full |
The Association Between the Extent of Glioblastoma Resection and Survival in Light of MGMT Promoter Methylation in 326 Patients With Newly Diagnosed IDH-Wildtype Glioblastoma |
title_fullStr |
The Association Between the Extent of Glioblastoma Resection and Survival in Light of MGMT Promoter Methylation in 326 Patients With Newly Diagnosed IDH-Wildtype Glioblastoma |
title_full_unstemmed |
The Association Between the Extent of Glioblastoma Resection and Survival in Light of MGMT Promoter Methylation in 326 Patients With Newly Diagnosed IDH-Wildtype Glioblastoma |
title_sort |
association between the extent of glioblastoma resection and survival in light of mgmt promoter methylation in 326 patients with newly diagnosed idh-wildtype glioblastoma |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Oncology |
issn |
2234-943X |
publishDate |
2020-07-01 |
description |
Background: The association between contrast enhanced (CE) and non-contrast enhanced (NCE) tumor resection and survival in patients with glioblastoma in relation to molecular subtypes is poorly understood. The aim of this study was to assess the association between CE and NCE tumor resection and survival in light of MGMT promoter methylation in newly diagnosed IDH-wildtype glioblastoma.Materials and methods: Patients with newly diagnosed IDH-wildtype glioblastoma who underwent surgery were eligible. CE and NCE tumor volumes were assessed on pre- and post-operative MRI scans and extent of resection was calculated. The association between CE and NCE tumor resection and survival was evaluated using multivariable Cox proportional hazards models and Kaplan Meier estimates.Results: Three hundred and twenty-six patients were included: 177 (54.3%) with and 149 (45.7%) without MGMT methylation. Multivariable Cox proportional hazards models stratified for MGMT methylation identified age ≤ 65y (HR 0.63; 95% CI, 0.49–0.81; p < 0.0001), chemoradiation (HR 0.13; 95% CI, 0.09–0.19; p < 0.0001), maximal CE tumor resection (HR 0.58; 95% CI, 0.39–0.87; p = 0.009), ≥ 30% NCE tumor resection (HR 0.71; 95% CI, 0.53–0.93; p = 0.014), and minimal residual CE tumor volume (HR 0.64; 95% CI, 0.46–0.88 p = 0.007) as being associated with longer overall survival. Kaplan Meier estimates showed that extensive surgery was more beneficial for patients with MGMT methylated glioblastoma.Conclusions: This study shows an association between maximal CE tumor resection, ≥30% NCE tumor resection, minimal residual CE tumor volume, and longer overall survival in patients with newly diagnosed IDH wildtype glioblastoma. Intraoperative imaging and stimulation mapping may be used to pursue safe and maximal resection. In future research, the safety aspect of maximizing tumor resection needs to be addressed. |
topic |
glioblastoma extent of resection contrast enhanced non-contrast enhanced survival MGMT |
url |
https://www.frontiersin.org/article/10.3389/fonc.2020.01087/full |
work_keys_str_mv |
AT fatihincekara theassociationbetweentheextentofglioblastomaresectionandsurvivalinlightofmgmtpromotermethylationin326patientswithnewlydiagnosedidhwildtypeglioblastoma AT fatihincekara theassociationbetweentheextentofglioblastomaresectionandsurvivalinlightofmgmtpromotermethylationin326patientswithnewlydiagnosedidhwildtypeglioblastoma AT marionsmits theassociationbetweentheextentofglioblastomaresectionandsurvivalinlightofmgmtpromotermethylationin326patientswithnewlydiagnosedidhwildtypeglioblastoma AT sebastianrvandervoort theassociationbetweentheextentofglioblastomaresectionandsurvivalinlightofmgmtpromotermethylationin326patientswithnewlydiagnosedidhwildtypeglioblastoma AT hendrikjandubbink theassociationbetweentheextentofglioblastomaresectionandsurvivalinlightofmgmtpromotermethylationin326patientswithnewlydiagnosedidhwildtypeglioblastoma AT peggynatmodimedjo theassociationbetweentheextentofglioblastomaresectionandsurvivalinlightofmgmtpromotermethylationin326patientswithnewlydiagnosedidhwildtypeglioblastoma AT johanmkros theassociationbetweentheextentofglioblastomaresectionandsurvivalinlightofmgmtpromotermethylationin326patientswithnewlydiagnosedidhwildtypeglioblastoma AT arnaudjpevincent theassociationbetweentheextentofglioblastomaresectionandsurvivalinlightofmgmtpromotermethylationin326patientswithnewlydiagnosedidhwildtypeglioblastoma AT martinvandenbent theassociationbetweentheextentofglioblastomaresectionandsurvivalinlightofmgmtpromotermethylationin326patientswithnewlydiagnosedidhwildtypeglioblastoma AT fatihincekara associationbetweentheextentofglioblastomaresectionandsurvivalinlightofmgmtpromotermethylationin326patientswithnewlydiagnosedidhwildtypeglioblastoma AT fatihincekara associationbetweentheextentofglioblastomaresectionandsurvivalinlightofmgmtpromotermethylationin326patientswithnewlydiagnosedidhwildtypeglioblastoma AT marionsmits associationbetweentheextentofglioblastomaresectionandsurvivalinlightofmgmtpromotermethylationin326patientswithnewlydiagnosedidhwildtypeglioblastoma AT sebastianrvandervoort associationbetweentheextentofglioblastomaresectionandsurvivalinlightofmgmtpromotermethylationin326patientswithnewlydiagnosedidhwildtypeglioblastoma AT hendrikjandubbink associationbetweentheextentofglioblastomaresectionandsurvivalinlightofmgmtpromotermethylationin326patientswithnewlydiagnosedidhwildtypeglioblastoma AT peggynatmodimedjo associationbetweentheextentofglioblastomaresectionandsurvivalinlightofmgmtpromotermethylationin326patientswithnewlydiagnosedidhwildtypeglioblastoma AT johanmkros associationbetweentheextentofglioblastomaresectionandsurvivalinlightofmgmtpromotermethylationin326patientswithnewlydiagnosedidhwildtypeglioblastoma AT arnaudjpevincent associationbetweentheextentofglioblastomaresectionandsurvivalinlightofmgmtpromotermethylationin326patientswithnewlydiagnosedidhwildtypeglioblastoma AT martinvandenbent associationbetweentheextentofglioblastomaresectionandsurvivalinlightofmgmtpromotermethylationin326patientswithnewlydiagnosedidhwildtypeglioblastoma |
_version_ |
1724510118826999808 |